References
- American National Standards Institute, American National Standards specifications for instruments to measure aural acoustic impedance and admittance (ANSI S3.39-1987). 1987. New York: ANSI.
- American National Standards Institute. Specifications for audiometers (ANSI S3.6-1996). 1996. New York: ANSI.
- Corder E.H., Robertson K., Lannfelt L., Bogdanovic N., Eggertsen G., et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 1998; 10: 1182–4
- Eichner J.E., Kuller L.H., Orchard T.J., Grandits G.A., McCallum L.M. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Card 1993; 71(2)160–5
- Friedman G., Froom P., Sazbon L., Grinblatt I., Shochina M., et al. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 1999; 52: 244–8
- Fullerton S.M., Strittmatter W.J., Matthew W.D. Peripheral sensory nerve defects in Apolipoprotein E knockout mice. Exp Neurol 1998; 153: 156–163
- Gold M., Lightfoot L.A., Hnath-Chisolm T. Hearing loss in a memory disorders clinic: An especially vulnerable population. Arch Neurol 1996; 53(9)922–928
- Guo, Y., Zhang, C., Du, X., Nair, U. & Yoo, T.J. 2005. Morphological and functional alterations of the cochlea in apolipoprotein E gene deficient mice. Hear Res, 208((1–2)), 54–67. Epub.
- Harrell R.W. Puretone Evaluation. Handbook of Clinical Audiology, J. Katz. Lippincott, Williams & Wilkins, Philadelphia 2002; 71–87
- Horsburgh K., Graham D.I., Stewart J., Nicoll J.A. Influence of apolipoprotein E genotype on neuronal damage and apoE immunoreactivity in human hippocampus following global ischemia. J Neuropathol Exp Neurol 1999; 58: 227–34
- Jones N.S., Davis A. A prospective case-control study of 50 consecutive patients presenting with hyperlipidaemia. Clin Otolaryngol Allied Sci 2001; 26: 89–96
- Jones N.S., Davis A. A retrospective case-controlled study of 1490 consecutive patients presenting to a neuro-otology clinic to examine the relationship between blood lipid levels and sensorineural hearing loss. Clin Otolaryngol Allied Sci 2000; 25: 511–7
- Jordan B.D., Relkin N.R., Ravdin L.D., Jacobs A.R., Bennett A. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing. JAMA 1997; 78: 136–40
- Kutner K.C., Erlanger D.M., Tsai J., Jordan B., Relkin N.R. Lower cognitive performance of older football players possessing apolipoprotein E epsilon 4. Neurosurgery 2000; 47: 651–7
- Lichtman S.W., Seliger G., Tycko B., Marder K. Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation. Neurology 2000; 55: 1536–9
- McCarron M.O., Muir K.W., Nicoll J.A., Stewart J., Currie Y., et al. Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke. Arch Neurol 2000; 57: 1480–4
- Menzel H.J., Kladetzky R.G., Assmann G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis. 1983; 983: 310–315
- Ray J. Is there a relationship between presbycusis and hyperlipoproteinemia? A literature review. J Otolaryngol 1991; 20: 336–41
- Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467–1472
- Sinha U.K., Hollen K.M., Rodriguez R., Miller C.A. Auditory system degeneration in Alzheimer's disease. Neurology 1993; 43: 779–785
- Sorbi S., Nacmias N., Piacentini S., Repice A., Latorraca S., et al. ApoE as a prognostic factor for post-traumatic coma. Nat Med 1995; 1: 852
- Tardiff B.E., Newman M.F., Saunders A.M., Strittmatter W.J., Blumenthal J.A., et al. Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Ann Thorac Surg 1997; 64(3)715–720
- Teasdale G.M., Nicoll J.A., Murray G., Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997; 350: 1069–71
- Torre P., Cruickshanks K.J., Klein B.E., Klein R., Hondahl D.M. The association between cardiovascular disease and cochlear function in older adults. J Speech, Lang and Hear Res 2005; 8: 473–481
- Wetter S., Murphy C. Apolipoprotein E (4 positive individuals demonstrate delayed olfactory event-related potentials. Neurobiol Aging 2001; 22: 439–447
- Willems P.J. Genetic causes of hearing loss. N Engl Med 2000; 342: 1101–1109
- Wilson P.W., Myers R.H., Larson M.G., Ordovas J.M., Wolf P.A. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. JAMA 1994; 272: 1666–1671